Published in Funct Neurol on January 05, 2016
Spinal and supraspinal factors in human muscle fatigue. Physiol Rev (2001) 7.58
Interneuronal relay in spinal pathways from proprioceptors. Prog Neurobiol (1992) 3.58
Differential effects on tonic and phasic reflex mechanisms produced by vibration of muscles in man. J Neurol Neurosurg Psychiatry (1966) 3.19
The responses of human muscle spindle endings to vibration of non-contracting muscles. J Physiol (1976) 2.89
Reflex origin for the slowing of motoneurone firing rates in fatigue of human voluntary contractions. J Physiol (1986) 2.85
Changes in presynaptic inhibition of Ia fibres at the onset of voluntary contraction in man. J Physiol (1987) 2.45
The use of vibration as an exercise intervention. Exerc Sport Sci Rev (2003) 2.27
Strength increase after whole-body vibration compared with resistance training. Med Sci Sports Exerc (2003) 2.23
Responses of mechanoreceptive afferent units in the glabrous skin of the human hand to sinusoidal skin displacements. Brain Res (1982) 1.78
Muscle spindle responses to stretch in normal and spastic subjects. Scand J Rehabil Med (1973) 1.53
General features of vibration-induced effects on balance. Ups J Med Sci (1972) 1.43
Stance- and locomotion-dependent processing of vibration-induced proprioceptive inflow from multiple muscles in humans. J Neurophysiol (2006) 1.23
Physiological characteristics of low-threshold mechanoreceptors in joints, muscle and skin in human subjects. Clin Exp Pharmacol Physiol (2005) 1.03
Effects of leg muscle tendon vibration on group Ia and group II reflex responses to stance perturbation in humans. J Physiol (2003) 1.02
Crossed effects of muscle vibration on motor-evoked potentials. Clin Neurophysiol (2001) 0.93
Temperature and criterion effects in a somatosensory subsystem: a neurophysiological and psychophysical study. J Neurophysiol (1982) 0.93
Medium-latency response to muscle stretch in human lower limb: estimation of conduction velocity of group II fibres and central delay. Neurosci Lett (1998) 0.92
Age effects on reflex and postural responses to propriomuscular inputs generated by tendon vibration. J Gerontol A Biol Sci Med Sci (1995) 0.85
A wearable proprioceptive stabilizer (Equistasi®) for rehabilitation of postural instability in Parkinson's disease: a phase II randomized double-blind, double-dummy, controlled study. PLoS One (2014) 0.84
Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia (2012) 2.48
Sudden stopping in patients with cerebellar ataxia. Cerebellum (2013) 1.97
Postinfectious neurologic syndromes: a prospective cohort study. Neurology (2013) 1.73
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet (2006) 1.56
Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol (2004) 1.43
Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia (2010) 1.40
Facilitated temporal processing of pain and defective supraspinal control of pain in cluster headache. Pain (2013) 1.22
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 1.20
The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain (2014) 1.17
Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain (2013) 1.16
Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes. Funct Neurol (2005) 1.12
Italian guidelines for primary headaches: 2012 revised version. J Headache Pain (2012) 1.10
The XX Ottorino Rossi award. Funct Neurol (2009) 1.08
Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain (2004) 1.08
Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology (2002) 1.05
Immune-mediated neuropathies in myeloma patients treated with bortezomib. Clin Neurophysiol (2008) 1.04
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med (2002) 1.00
Nitroglycerin induces hyperalgesia in rats--a time-course study. Eur J Pharmacol (2003) 0.99
The Headache Under-Response to Treatment (HURT) Questionnaire: assessment of utility in headache specialist care. Cephalalgia (2012) 0.97
Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord (2006) 0.97
Sexual function and distress in women treated for primary headaches in a tertiary university center. J Sex Med (2012) 0.96
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain (2011) 0.95
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis (2010) 0.95
Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett (2002) 0.95
Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study. Eur J Pain (2010) 0.93
Muscle MRI in adult-onset acid maltase deficiency. Neuromuscul Disord (2004) 0.92
Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study. Mov Disord (2014) 0.92
ALS dysphagia pathophysiology: differential botulinum toxin response. Neurology (2013) 0.91
Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts. Cephalalgia (2010) 0.91
Chronic daily headache. Expert Rev Neurother (2008) 0.90
Identification of novel pharmacological targets to minimize excitotoxic retinal damage. Int Rev Neurobiol (2009) 0.90
SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis. Neurobiol Dis (2010) 0.90
Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain (2010) 0.89
Identification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat. Brain Res (2009) 0.89
An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain (2012) 0.89
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol. FEBS J (2007) 0.89
Gait pattern in inherited cerebellar ataxias. Cerebellum (2012) 0.88
Tolerability of the triptans: clinical implications. Drug Saf (2003) 0.88
Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neurooncol (2013) 0.88
Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology (2005) 0.87
Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization. Mov Disord (2011) 0.87
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs (2007) 0.87
Reduced-intensity modified constraint-induced movement therapy versus conventional therapy for upper extremity rehabilitation after stroke: a multicenter trial. Neurorehabil Neural Repair (2012) 0.87
Headache yesterday in Europe. J Headache Pain (2014) 0.87
Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache (2012) 0.87
Four-week trunk-specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease. Mov Disord (2010) 0.87
Use of complementary and alternative medicine by patients with cluster headache: results of a multi-centre headache clinic survey. Complement Ther Med (2007) 0.87
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model. J Headache Pain (2014) 0.86
Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature. Funct Neurol (2004) 0.86
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia. Neurol Sci (2008) 0.86
A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. Int Rev Neurobiol (2007) 0.86
Effects of anandamide in migraine: data from an animal model. J Headache Pain (2011) 0.86
Caregivers burden and needs in community neurorehabilitation. J Rehabil Med (2010) 0.86
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens (2011) 0.85
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. J Inherit Metab Dis (2010) 0.85
Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs (2003) 0.84
The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med (2010) 0.84
Experimental muscle pain decreases the frequency threshold of electrically elicited muscle cramps. Exp Brain Res (2007) 0.84
Kinematic and electromyographic study of the nociceptive withdrawal reflex in the upper limbs during rest and movement. J Neurosci (2006) 0.84
Lower limb antagonist muscle co-activation and its relationship with gait parameters in cerebellar ataxia. Cerebellum (2014) 0.84
Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test. Eur J Pharmacol (2006) 0.84
Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. Neurol Sci (2008) 0.84
Improving neuro-oncological patients care: basic and practical concepts for nurse specialist in neuro-rehabilitation. J Exp Clin Cancer Res (2012) 0.83
Modelling the spine as a deformable body: Feasibility of reconstruction using an optoelectronic system. Appl Ergon (2012) 0.83
Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity. J Headache Pain (2010) 0.83
Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain (2013) 0.83
Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment. Mult Scler (2004) 0.83
The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms. Clin Neurophysiol (2011) 0.83
The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study. Parkinsonism Relat Disord (2009) 0.83
Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. Headache (2012) 0.82
An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans. J Pain (2013) 0.82
Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception (2013) 0.82
Turning strategies in patients with cerebellar ataxia. Exp Brain Res (2012) 0.82
Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. J Neurooncol (2011) 0.82
Pathogenetic role of myelitis for syringomyelia. Clin Neurol Neurosurg (2007) 0.82
Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations. Neurogenetics (2011) 0.82
Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the 'CARE' protocol). Cephalalgia (2013) 0.82
Neurophysiological approach to central pain modulation in primary headaches. J Headache Pain (2005) 0.82
Lack of trigemino-cervical reflexes in progressive supranuclear palsy. Mov Disord (2008) 0.81
Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine. J Headache Pain (2015) 0.81
Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease. Brain Res (2007) 0.81
Effects of nimesulide on nitric oxide-induced hyperalgesia in humans--a neurophysiological study. Eur J Pharmacol (2002) 0.81
Facilitated temporal summation of pain at spinal level in Parkinson's disease. Mov Disord (2010) 0.81
Differences in the EMG pattern of leg muscle activation during locomotion in Parkinson's disease. Funct Neurol (2004) 0.81
In search of new targets for retinal neuroprotection: is there a role for autophagy? Curr Opin Pharmacol (2012) 0.81
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model. Auton Neurosci (2012) 0.81